These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30051929)

  • 1. Opioid utilization patterns in United States individuals with sickle cell disease.
    Ballas SK; Kanter J; Agodoa I; Howard R; Wade S; Noxon V; Dampier C
    Am J Hematol; 2018 Oct; 93(10):E345-E347. PubMed ID: 30051929
    [No Abstract]   [Full Text] [Related]  

  • 2. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating palliative care and emergency medicine for optimal management of sickle cell pain in the wake of the United States opioid epidemic.
    Effiong A; Kumari P
    Ann Palliat Med; 2018 Apr; 7(2):274-276. PubMed ID: 29307211
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioids for Acute Pain: Proceed with Caution.
    Visconti A
    Am Fam Physician; 2018 Feb; 97(3):203-204. PubMed ID: 29431980
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
    Telfer P; Bahal N; Lo A; Challands J
    Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Stehouwer N; Edge P; Katie Park B; Piccone C; Little J
    Am J Hematol; 2017 Apr; 92(4):E40-E42. PubMed ID: 28066934
    [No Abstract]   [Full Text] [Related]  

  • 7. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Complex Association of Daily Opioid Dose with Visits for Pain in Sickle Cell Disease: Tolerance or Treatment-Refractory Pain?
    Prince EJ; Pecker LH; Lanzkron S; Carroll CP
    Pain Med; 2023 Jun; 24(6):703-712. PubMed ID: 36458906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in the use and cost of opioids to treat acute and chronic pain in injured workers, 1999 to 2009.
    Bernacki EJ; Yuspeh L; Lavin R; Tao XG
    J Occup Environ Med; 2012 Feb; 54(2):216-23. PubMed ID: 22267188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of severe chronic pain with methadone in pediatric patients with sickle cell disease.
    LeBlanc Z; Vance C; Payne J; Zhang J; Hilliard L; Lebensburger JD; Howard TH
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27084. PubMed ID: 29749702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Still seeking balance in opioid management for acute sickle cell disease pain.
    Fasipe TA; Hulbert ML
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29741. PubMed ID: 35522166
    [No Abstract]   [Full Text] [Related]  

  • 12. [Not Available].
    Schneider T; Ruppen W
    Ther Umsch; 2017; 74(5):277-283. PubMed ID: 29083286
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic.
    Skolnick P; Volkow ND
    Neuron; 2016 Oct; 92(2):294-297. PubMed ID: 27764663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.
    Larochelle MR; Zhang F; Ross-Degnan D; Wharam JF
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):885-92. PubMed ID: 25906971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and emerging treatments for vaso-occlusive pain in sickle cell disease.
    Dampier C
    Expert Rev Hematol; 2019 Oct; 12(10):857-872. PubMed ID: 31364883
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries.
    Dilokthornsakul P; Moore G; Campbell JD; Lodge R; Traugott C; Zerzan J; Allen R; Page RL
    J Pain; 2016 Apr; 17(4):436-43. PubMed ID: 26721613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal fentanyl works-Why are we not using it more to treat acute pain in sickle cell disease?
    Oni MO; Archer NM
    Am J Hematol; 2023 Apr; 98(4):564-565. PubMed ID: 36746630
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of Opioid Prescribing Patterns in the United States and Japan: Primary Care Physicians' Attitudes and Perceptions.
    Onishi E; Kobayashi T; Dexter E; Marino M; Maeno T; Deyo RA
    J Am Board Fam Med; 2017; 30(2):248-254. PubMed ID: 28379832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.
    Lanzkron S; Carroll CP; Haywood C
    Am J Hematol; 2010 Oct; 85(10):797-9. PubMed ID: 20730795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis.
    Payne J; Aban I; Hilliard LM; Madison J; Bemrich-Stolz C; Howard TH; Brandow A; Waite E; Lebensburger JD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27420. PubMed ID: 30151977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.